Researchers discover treatable cause of severe anemia associated with a cancer therapy
Researchers at Mount Sinai Tisch Cancer Center identify a treatable folate deficiency causing severe anemia in some cancer patients receiving PARP inhibitors. Routine folic acid screening could reduce hospitalizations and treatment interruptions.
anemia cancer therapy folate deficiency PARP inhibitors Mount Sinai
Linked Entities
Contributing Articles
An initial medical check on Manchester United target Ederson raised concerns
Yahoo Sports —
England World Cup winner Stiles died with brain injury, court told
Yahoo Sports —
General purpose AI . . . and other research
BMJ News —
Most obesity drugs do not improve quality of life or reduce cardiovascular risk, analysis finds
BMJ News —
Rapid endometriosis tests to be made available on NHS in England and Wales
The Guardian —
Researchers discover treatable cause of severe anemia associated with a cancer therapy
Medical Xpress —